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Acceptance of the fetal semi-allograft by the mother’s immune system has become the
focus of intensive research. CD4+ T cells are important actors in the establishment of
pregnancy. Th1/Th2 paradigm has been expanded to include CD4+ regulatory T (Treg) and
T helper 17 (Th17) cells. Pregnancy hormones exert very significant modulatory properties
on the maternal immune system. In this review, we describe mechanisms by which the
endocrine milieu modulates CD4 T cell polarization during pregnancy. We first focused on
Treg andTh17 cells and on their importance for pregnancy. Secondly, we review the effects
of pregnancy hormones [progesterone (P4) and estradiol (E2)] on immune cells previously
described, with a particular attention to human chorionic gonadotropin (hCG). The impor-
tance of Treg cells for pregnancy is evidenced. They are recruited before implantation and
are essential for pregnancy maintenance. Decreased number or less efficient Treg cells
are implicated in fertility disorders. As forTh17 cells, the few available studies suggest that
they have a negative impact on fertility. Th17 frequency is increased in infertile patients.
With the combination of its pro-effects on Th2 and Treg cells and anti-effects on Th1 and
Th17 cells, P4 contributes to establishment of a favorable environment for pregnancy. E2
effects are more dependent on the context but it seems that E2 promotes Treg and Th2
cells while it inhibits Th1 cells. hCG positively influences activities of Treg and uterine nat-
ural killer cells. This embryo signal is an essential actor for the success of pregnancy, both
as the endocrine factor regulating P4 secretion by the ovarian corpus luteum, but also as
a paracrine agent during implantation as well as an angiogenic and immunologic media-
tor during the course of gestation. Luteinizing hormone (LH) immune properties begin to
be studied but its positive impact on Treg cells suggests that LH could be a considerable
immunomodulator in the mouse.
Keywords: progesterone, estradiol, human chorionic gonadotropin, luteinizing hormone, regulatoryT cells,T helper
17 cells, pregnancy
INTRODUCTION
Pregnancy constitutes an immunological paradox since it implies
that a fetus semi-antigenically distinct from the mother is not
rejected by her immune system from embryo implantation to
delivery. Peter Medawar was the first to consider the fetus as a semi-
allograft and to suggest a major role for the immune system in
ensuring maintenance of pregnancy (1). Since then, the establish-
ment of tolerance of mother’s immune system to the embryonic
and fetal semi-allograft has become the focus of intensive research.
Uterine Natural Killer (uNK) cells have been demonstrated to
be main actors of pregnancy with their effects on angiogenesis, vas-
cular remodeling, trophoblast invasion, and cytokine production
(2, 3). CD4+ T cells are also important actors in the establishment
of a «pregnancy favorable environment», and the Th1/Th2 para-
digm has been prevailing for years. Briefly, feto-maternal accep-
tance was explained by Th2 profile predominance essential for
pregnancy while pro-inflammatory Th1 cytokines were shown to
be downregulated (4). This Th1/Th2 paradigm has been expanded
to include CD4+ regulatory T (Treg) cells and interleukin-17 (IL-
17) expressing T [T helper 17 (Th17)] cells since it appeared that
some studies were not fitting with the original theory (5, 6).
The endocrine system is also essential for the programing
of a tolerogenic environment favorable to embryo implanta-
tion and fetal development, in particular the pregnancy hor-
mones progesterone (P4), estradiol (E2), and human chorionic
gonadotropin (hCG) hormone. Actually, both endocrine and
immune systems are intimately linked and pregnancy hormones
exert very significant modulatory properties on the maternal
immune system.
Here, we review the mechanisms by which the endocrine milieu
modulates CD4 T-lymphocyte polarization during pregnancy.
First, we will focus on Treg and Th17 cells, on their importance
for pregnancy, as well as their implication in infertility disor-
ders. Second, we will review the effects of pregnancy hormones
on immune cells previously described, with a particular attention
to hCG.
www.frontiersin.org July 2014 | Volume 5 | Article 106 | 1
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Polese et al. T-cell endocrine regulation during pregnancy
CD4 T CELLS IMPORTANT FOR PREGNANCY
TH1 AND TH2 CELLS
CD4+ T cells are heterogenous members of the adaptative
immune system. Different subsets have been identified based on
their distinct cytokine and transcriptional profiles. Each subset has
different effector functions. To be short, Th1 cells are polarized
by IL-12 and are characterized by high production of interferon-
gamma (IFNγ). Th2 cells are polarized mainly by IL-4 and produce
a cytokine profile including IL-4, IL-5, IL-6, and IL-13. Th2 are
important for the clearing of extra-cellular pathogens and for
helping B cells to produce antibodies. A balance between Th1
and Th2 is important for immune response, and Th1 and Th2
differentiation is mutually exclusive (7). In the context of preg-
nancy, Th1/Th2 balance was seen as essential for determining fetus
survival in the maternal uterus. Th2 predominance was consid-
ered to be essential for fetal survival while a polarized Th1 profile
could promote fetal rejection (4, 8–11). Th1/Th2 proportions dur-
ing human pregnancy are simplified in Figure 1. However, the
Th1/Th2 paradigm has been challenged by some recent studies
that, for example, showed that Th2 cytokines KO mice (IL-4/IL-10
double KO mice) had no fertility disorders (12). For a complete
review about the questioning of Th1/Th2 paradigm, please refer
to the comprehensive review of Chaouat (5).
TREG CELLS
During the 1990s, Sakaguchi identified a T cell subpopulation nat-
urally present in the immune system indispensable for tolerance
and immune homeostasis. Those cells specialized in suppres-
sion/regulation of the immune response were called Treg cells (18)
that were characterized first by increased CD25 expression at their
surface (18). In 2003, Foxp3 was then discovered as the specific
transcription factor that induces Treg cell differentiation (19). Treg
cells are phenotypically and functionally heterogenous. Currently,
various subsets of Treg cells in immune system have been identified
(20). One common classification distinguishes thymic Treg (tTreg)
generated in the thymus by a selection process from peripheral
Treg or inducible Treg (iTreg) developing in the periphery from
naïve T cells after antigenic stimulation. It has been shown that
FIGURE 1 | Pregnancy hormones and CD4+T cells blood levels during
human pregnancy. hCG is an embryonic signal that announces the presence
of an embryo to the maternal organism. hCG gene is transcribed as early as
the eight-cells stage but it cannot be detected in the maternal blood before
the second week after fertilization. Blood hCG concentration reaches a peak
between the 8th and 11th week then it declines and stays low until the end of
pregnancy. E2 is mainly produced by ovarian granulosa cells and by placenta.
E2 concentration in maternal blood increases gradually after the first week,
reaches a peak before parturition then drops few days after. Secreted mainly
by corpus luteum then by placenta after 12 weeks of pregnancy, small
quantities of P4 are already produced at the follicle stage. Then, P4
concentration in the blood increases strongly during the course of pregnancy
to reach a peak before parturition. Relative blood levels of CD4+T cells are
compiled from different articles. During healthy pregnancy, Th1 cells are
downregulated while Th2 cells are upregulated (13). Th2 predominance is
considered to be essential for fetal survival. Pregnancy is also associated with
a systemic expansion of Treg cells. The level of Treg cells is on the peak during
the second trimester (14, 15). The circulating level of Th17 cell does not vary
during human pregnancy and stays low (16). They are decreased during
pregnancy when compared to non-pregnant women (17).
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CNS1 at the Foxp3 locus is not required for tTreg differentiation
while it is essential for iTreg generation (21). The Treg cell fam-
ily includes also IL-10-secreting CD4+ T regulatory-1 cells (Tr1)
and TGF-β-secreting CD4+ Th cells (Th3). Treg cells exert their
suppressive functions by different mechanisms such as secretion
of inhibitory cytokines, cytolysis or metabolic disruption of the
target cell and modulation of antigen presentation (20). As major
actors for immunological tolerance, their impact on the acceptance
of the fetus by the mother has been explored.
It is now more and more demonstrated that Treg cells are
important cells for embryo implantation and pregnancy. Aluvi-
hare et al. were the first to demonstrate that Treg cells mediate
maternal tolerance to the fetus in the mouse (22). They observed a
systemic expansion of the maternal CD4+CD25+T cell pool dur-
ing pregnancy and expression of Foxp3 by uterine CD4+CD25+
cells. They demonstrated also that CD25+ T cells depletion leads
to gestation failure. Two studies confirmed this important role
of Treg cells in human pregnancy (14, 23). Figure 1 depicts Treg
cell blood levels during human pregnancy. Later, Zenclussen and
her colleagues observed that a decrease in Treg cell activity leads
to spontaneous abortion and they also demonstrated that adop-
tive transfer of Treg cells is able to prevent fetal rejection in a
murine abortive model (24). They showed afterwards that the
transferred Treg cells act by creating a privileged tolerant envi-
ronment, and by up-regulating leukemia inhibitory factor (LIF),
TGF-β, and HO-1 levels (25). Tilburgs et al. reported selective
migration of specific Treg cells from blood to the decidua in
human pregnancy (26). Then, seminal fluid was shown to drive
expansion of CD4+CD25+ cells in mouse (27). By injecting anti-
CD25 mAb in pregnant mice at different time of pregnancy, Shima
et al. demonstrated that Treg cells are necessary for implantation
and maintenance of early pregnancy but not late pregnancy in
allogeneic mice (28). Over the years, the in-depth study of Treg
cells gave rise to the question of which subtype of Tregs is really
acting during pregnancy (29). Samstein et al. studied this issue
for the first time. They demonstrated that iTregs play important
role in maintenance of pregnancy by using CNS1-deficient female.
Those females present an increased frequency in fetal resorption
(30). Zenclussen and her team were also interested in this sub-
ject. By using Helios as a marker of tTreg cells (31), they showed
that tTreg cells are important for mouse pregnancy establishment
while iTregs act at later pregnancy stages (32). Recently, Rowe et al.
showed in mice that specific fetal Treg cells persist after delivery
and re-accumulate during subsequent pregnancy in order to sus-
tain protective regulatory memory to fetal antigen (33). The study
of memory Treg cells across pregnancy remains another important
topic to explore in the near future.
In addition, some papers evidenced a Treg cell dysregulation in
infertile patients. A decrease in the decidual Treg cell number has
been reported in human miscarriage (23). Endometrial expression
of Foxp3 mRNA is decreased in women with primary unexplained
infertility (34). Treg frequency in women with recurrent pregnancy
lost do not fluctuate during menstrual cycle in comparison with
fertile women, but Treg cell function in those women is deficient
(35). The suppressor activity of iTregs in those patients is also
decreased (36). Regarding preeclampsia (PE), it has been reported
that PE patients present decreased Treg cell level in blood and
in decidua (17, 37, 38). Moreover, Treg cell function has been
found to be decreased in PE patients (39). Recently, Inada et al.
showed that the population of decidual non-proliferating Foxp3+
Tregs is significantly smaller in cases of miscarriages than in nor-
mal pregnancy (40). This suggests that non-proliferating Treg
cells are important for induction of immune tolerance. Finally,
in the CBA×DBA/2 well-known mouse model of abortion (41),
a decreased number in Treg cells has also been reported (24). Alto-
gether, those studies demonstrate that abnormalities in Treg cell
frequency and function exert a negative impact upon fertility and
confirm their importance for pregnancy.
TH17 CELLS
T helper 17 cells are a lineage of CD4+ T cells characterized by
the secretion of IL-17a and IL-17f cytokines (42, 43) and by the
expression of RORc (RORγt in mice) specific transcription fac-
tor (44). TGF-β, IL-6, IL-21, and IL-23 are important for their
differentiation. It has to be mentioned that Th17 differentia-
tion in mice is quite different from this process in humans (45).
By the secretion of IL-17 cytokines, Th17 trigger recruitment,
activation, and migration of neutrophils but also liberation of
pro-inflammatory mediators. Th17 cells produce other cytokines
too. IL-21 is involved in expansion of activated B cells and in
class switching of immunoglobulin isotypes. The secretion of IL-
21 can also contribute to an autoamplification loop of Th17 cells
by inducing their own differentiation. As for IL-22 production,
it impacts on epithelial and endothelial barrier function through
a dual effect on inflammation and tissue repair induction (46).
Thus, Th17 cells are important effector cells for defense against
extra-cellular pathogens. They are also associated with the patho-
genesis of several autoimmune and inflammatory diseases (45).
This complexity of Th17 cells is further amplified by their plastic-
ity and instability. They can acquire other phenotypes depending
on the cytokine environment (47). Giving the increasing demon-
stration of Th17 cell importance in the homeostasis of the immune
system, their influence during pregnancy began to be investigated
in the past few years.
Santner-Nanan et al. first found a lower Th17 cell frequency
during pregnancy compared with non-pregnant women (17).
Another article showed that the circulating level of Th17 cells does
not vary during human pregnancy (see Figure 1) and that decid-
ual levels of Th17 cells are higher than in peripheral blood (16).
On the contrary, Mjosberg et al. found fewer Th17 cells in human
decidua than in blood in early pregnancy and highlighted their
nearly absence in decidua (48). Recently, it has been shown that
NK cells promote tolerance by dampening Th17 cells via IFNγ at
materno-fetal interface, in humans and mice (49). All those results
suggest that pregnancy is associated with a decrease in Th17 fre-
quency. This is in agreement with another paper showing that
placental trophoblasts in culture with T lymphocytes inhibit Th17
cells while promoting Th2 (50). Actually, not much is known about
Th17 physiology during normal pregnancy, and most of articles
focus on their presence in infertile patients.
The proportion of Th17 cells has been shown to be higher in
blood and decidua of patients with unexplained recurrent sponta-
neous abortion (51, 52). Th17 factors like RORc and IL-17 are also
higher in deciduas of those women. Nakashima et al. found also
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a high number of IL-17 positive cells in decidua of abortion case
and suggested that Th17 cells could be involved in induction of
inflammation in the late stage of abortion (53). Ito et al. suggested
that Th17 cells could promote inflammation at the feto-maternal
interface in preterm delivery, a disorder associated with infection
and uterine inflammation (54). Furthermore, it was shown that
circulating Th17 cells are increased in PE patients compared with
healthy pregnant women (17). Others confirmed those results (39,
55). In a recent and well-thought article, it has been shown that NK
cell-mediated inhibition of Th17 is lost in patients with recurrent
spontaneous abortion, leading to a Th17 response and inflamma-
tion (49). Elevated IL-17 levels have also been observed in plasma
of patients suffering from unexplained infertility (56). Altogether,
those results indicate that Th17 cells seem to exert a negative
impact upon fertility. Not much is known about their physiological
role during estrous cycle and pregnancy but their presence is asso-
ciated with inflammation and infertility. Given the importance
of some temporary inflammation state for embryo implantation
(57), it would be interesting to better study their exact importance
during estrous cycle and early normal pregnancy.
IMMUNOMODULATORY PROPERTIES OF PREGNANCY
HORMONES
PROGESTERONE
Progesterone is a crucial hormone in the female reproductive sys-
tem. Secreted by the ovarian corpus luteum (CL) then by placenta
after 12 weeks of pregnancy, it regulates endometrium modifica-
tions across the cycle and decidualization in order to prepare the
uterus for embryo implantation. P4 plasma levels during human
pregnancy are illustrated on Figure 1. Most importantly, P4 has
a major impact on establishment and maintenance of pregnancy.
Besides its endocrine effects, P4 has immunological properties.
In particular, its immunosuppressive effects are known for a long
time (58).
In 1995, Piccinni et al. demonstrated that P4 favors the develop-
ment of Th2 CD4+ T cells (59). They suggested that P4 could be
responsible at least in part for the Th2 predominance of pregnancy.
A few years later, it was shown that P2 acts via an immunomod-
ulatory protein called P4-inducible blocking factor (PIBF) that
increased the production of Th2 cytokines by mice lymphocytes
(60). This pro-Th2 effect of P4 is consistent with the increased
IL-4 production observed during luteal phase of the ovarian cycle
that is associated with elevated levels of P4 and estrogens (61).
Moreover, P4 directly inhibits Th1 development while enhanc-
ing Th2 polarity in mouse cells (62), and P4 down-regulates the
expression of IFN-γ during luteal phase (63). The emergence of
the Th1/Th2/Treg/Th17 paradigm led to the study of P4 on those
cells too. Mjosberg et al. pointed out the P4 regulatory role on
Treg cells during human pregnancy (64). In vivo and in vitro mod-
els indicate that P4 increases the proportion of Treg cells but also
enhances their suppressive capacity (65). The association between
Treg and P4 levels was confirmed in humans (66) and Lee et al.
showed that P4 promotes the differentiation of human cord blood
fetal T cells into Treg cells (67). P4 also promotes generation of
iTreg cells that are highly stable (68), while it suppresses murine
Th17 cells. In human and murine T cells, P4 inhibits differen-
tiation of Th17 and decreases associated factors like RORc and
IL-17a. Recently, it was shown that P4 inhibits Th17 response
while enhancing Treg development in murine vaginal gonococ-
cal infection (69). Some researchers were curious to know how P4
acts on T cells. Membrane P4 receptors are found in human T cells
(70). On the other hand, Treg cell expansion has been suggested
to involve nuclear P4 receptors (65). Finally, Lee suggested that
both nuclear and non-nuclear receptors are concerned (68). PIBF
is one of the target genes of P4 in pregnancy lymphocytes. It sig-
nals via Jak1/Stat6 pathway to regulate cytokines expression (71,
72). Altogether, those studies suggest that P4 favors Th2 and Treg
cells whilst dampening Th1 and Th17. Thus, P4 seems to partici-
pate in establishment of favorable environment for pregnancy by
its effects on T cells.
ESTROGENS
Estrogens are also important for female reproductive tract, namely
E2, estrone (E1), and estriol (E3). E2 is mainly produced by
ovarian granulosa cells and by placenta. Figure 1 illustrates E2
plasma levels during human pregnancy. E2 immunomodulatory
roles are multiple (73) but there is a paradox between their pro-
and anti-inflammatory effects. Particularly, modifications in the
clinical state of autoimmune diseases states observed in pregnant
patients are distinct when looking at different kinds of diseases.
For example, a remission of rheumatoid arthritis (RA) is usually
observed in pregnant women (74) while a worsening of symptoms
can be noticed during pregnancy for women suffering from sys-
temic lupus erythematosus (SLE) (75). Those observations could
be explained by the distinct effects of E2 on immune cell types.
Estradiol receptors (ER)α and β are nuclear receptors expressed
on most immune cells (76), including human and murine lym-
phocytes (77–80). Human CD4+ T cell express ERα at higher
levels than B cells (81). These observations led to the study of
the immunological properties of E2. E2 up-regulates IFN-γ levels
in murine splenic lymphocytes (82) and, in non-obese diabetic
(NOD) mice, E2 increase IFN-γ production by CD4+ Th1 cells
(83). Maret has shown that E2 promotes Th1 cells responses and
that requires ERα (84). E2 modulates cytokines and chemokines
expression by human and murine dendritic cells (85, 86), which
influences secondarily T cell response. E2 acts also on CCR expres-
sion and function in murine T lymphocytes (87). In addition to
pro-Th1 effects, E2 acts on Th2 cells. Indeed, the increase of IL-4
observed during the luteal phase (corresponding to P2 and E2 high
levels) could be caused also by E2 (61). E2 also increases secretion
of IL-4 by CD4+ T cells as well as GATA-3 expression in mice
(88). Anti- and pro-inflammatory effects have been reported for
E2 since it enhances both IL-10 and IFN-γ secretion in humans
(89). So, E2 would have stimulating effects both on Th2 and Th1.
With regard to the Th1/Th2 paradigm of pregnancy, both pro-Th1
and Th2 roles are paradoxical. Doria and others have explained this
paradox by stating that, with high E2 levels such as in pregnancy,
Th1 development is inhibited while Th2 polarity is favored. This
is consistent with the improvement of Th1-mediated diseases and
the worsening of Th2-mediated diseases observed during preg-
nancy (90). On the contrary, by promoting Th2 responses, E2
tends to worsen Th2-mediated diseases like SLE. Study of the E2
impact upon Treg cells has been widely explored, clarifying the sit-
uation. First, Polanczyk et al. discovered that E2 enhances Foxp3
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expression in vivo and in vitro (91). They suggested for the first
time that E2 helps to regulate fetal tolerance during pregnancy by
expanding Treg cells. One year later, the same team showed that
E2 also increases the suppressive function of Treg cells. Similarities
between pregnant mice and E2-treated mice suggested that E2 was
mainly implicated in Treg cell expansion during pregnancy (92).
Again, they demonstrated that E2 reduces activation of effector T
cells while promoting Treg cell function in mice (93). Prieto et al.
also showed that E2 promotes human Treg cell proliferation and
enhances their suppressive functions (94). By showing that Treg
cell frequency and E2 levels are correlated in humans, Arruvito
et al. corroborated the pro-Treg effect of E2 (35). This correlation
between E2 and Treg cells was confirmed in mouse models by Tai
et al., who demonstrated that E2 addition converts CD4+CD25−
T cells in CD4+CD25+ Treg cells and enhances Foxp3 and IL-
10 expression (95). Later, Valor et al. confirmed that E2 enhances
Treg cell number and function in humans (96). Concerning Th17
cells, it has been shown for a long time that E2 suppresses experi-
mental allergic encephalomyelitis (EAE), a Th17-mediated disease
(97, 98), and E2 inhibits IL-17 production by murine lymphocytes
(99). On the contrary, Khan et al. found that E2 promotes IL-17
production as well as RORγ expression in stimulated splenocytes
in mice (100). Even if those studies revealed contradictory results,
they suggest that E2 regulates Th17 cells, perhaps depending on the
context. In EAE, the E2 protective effects seem to be due to Th17
inhibition (101). Recently, it has been also shown that E2 exerts
inhibitory effects on Th17 cells in the bone environment (102).
Ovariectomized mice have increased Th17 cells and associated
factors in bone marrow, and this was reversed by E2 supplemen-
tation. So, it seems that E2 impact on Th17 depends on the tissue
and disease context. However, most studies tend to show that E2
has an inhibitory role on Th17 cells. Concerning the impact of
E2 on T cells, we can conclude that they are quite large. E2 can
promote Th1, Th2, Treg, and Th17 cells depending on the context.
E2 have also inhibitory impact on those cells. During pregnancy,
it seems that E2 favors Th2 and Treg cell development while it
dampens Th1 responses. There has been no study so far to explore
the effect of E2 on Th17 during pregnancy. Concerning the mole-
cular mechanisms implicated in the immunomodulatory roles of
E2, a recent article has shown that those E2 effects are mediated
through its receptors and involve intracellular signaling pathways
like ERK, CREB, and Akt, as well as antioxidant enzymes (103).
HUMAN CHORIONIC GONADOTROPIN
Human chorionic gonadotropin is the most specific embryo-
derived signal observed in humans and the hCG gene is tran-
scribed as early as the eight-cell stage, before embryo implantation
(104–107). This signal announces the presence of an embryo to
the maternal organism. The hCG plasma level during human
pregnancy is depicted in Figure 1. hCG belongs to the glycopro-
tein hormone family such as luteinizing hormone (LH), follicle-
stimulating hormone (FSH), and thyroid stimulating hormone
(TSH). Composed of two subunits, the alpha subunit is identical
for all the members of the family while the hCG beta subunit shows
96% of homology with LH beta subunit. LH and hCG share the
same LHCG receptor (LHCG-R). The basic endocrine function of
hCG is to promote pregnancy via CL survival and stimulation
of P4 production. Being released before embryo implantation,
hCG also acts on endometrial cells in a paracrine way. For exam-
ple, hCG induces morphological and functional differentiation
of endometrial stromal cells into decidua (108). The investiga-
tors demonstrated that hCG induce prolactin secretion by human
endometrial stromal cells, which is a sign of decidualization. Fur-
thermore,hCG controls LIF and IL-6 secretion by human endome-
trial cells, and these two cytokines are known to influence blas-
tocyst implantation (109). Indeed, we showed that endometrial
epithelial cells cultured with hCG secrete higher LIF level while
showing decreased IL-6 secretion. Furthermore, hCG has angio-
genic and immunological properties, as reviewed in a recent paper
(110). Briefly, hCG promotes angiogenesis by increasing vessel for-
mation and pericyte sprouting and maturation in several in vitro
and in vivo experimental models (111–115). hCG also influences
angiogenic molecule production like vascular endothelial growth
factor (VEGF) (113, 116). In this respect, hCG is considered to
be an angiogenic factor (117). By promoting angiogenesis and
vasculogenesis, hCG allows placenta to have adequate blood sup-
ply during the invasion of uterus and optimum nutrition to the
fetus. The immunomodulatory properties of hCG are multiple
and extremely important. First, hCG has a positive impact on uNK
cells, the predominant leukocyte subtype of the gravid uterus that
acts on establishment and maintenance of pregnancy, in humans
and mice (2, 3, 118). Particularly, uNK cells contribute to essential
vascular changes by regulating the remodeling of decidual spiral
arterioles (119, 120) and by secreting angiogenic factors as mem-
bers of VEGF family (121). It has been shown that hCG regulates
uNK proliferation (122). A dose-dependant increase in uNK pro-
liferation is observed when isolated human uNK are incubated
with hCG (123). Since uNK cells do not express the LHCG-R (124),
hCG would act on mannose receptor (MR), which is expressed by
human uNK (123). Furthermore, hCG promotes monocyte func-
tion and their IL-8 production (125), and also induces macrophage
functions (126). This promotes clearance of apoptotic cells and
defense against infections, two relevant mechanisms for pregnancy
maintenance. hCG influences also dendritic cell differentiation
and function, decreasing their ability to stimulate T cell prolifer-
ation (127). Finally, hCG has different effects on CD4+ T cells.
During the 1970s, hCG was suggested to have effects on maternal
lymphocytes (128). Khan revealed that hCG treatment of NOD
mice prevent them to develop diabetes, a Th1 disease. The inves-
tigators demonstrated that hCG injections in NOD mice before
the onset of diabetes avoid the apparition of inflammatory infil-
trate in pancreas and reduce hyperglycemia. They proved that hCG
inhibits murine Th1 cells and their production of IFN-γ (129). A
few years later, Khil confirmed those results and added new infor-
mation. He showed that hCG effects on NOD mice implied an
inhibition of T cell proliferative responses as well as an increase of
CD4+CD25+ cells (130). He revealed that CD4+CD25+ deple-
tion cancels the protective effects of hCG treatment on diabetes
development. Recently, studies about hCG impact on Treg cells
have been carried out. Schumacher et al. explored Treg cell recruit-
ment at the human materno-fetal interface and demonstrated with
migration assays that hCG attracts them during early pregnancy
(131). The same group also showed that hCG increases murine
Treg cell frequency in vivo and their suppressive activity in vitro
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FIGURE 2 | hCG and LH functions during human and murine pregnancy.
Besides its endocrine role, hCG also acts on endometrial cells in a paracrine
way and induces morphological and functional differentiation of endometrial
stromal cells into decidua. hCG controls LIF and IL-6 secretion by human
endometrial cells. By promoting angiogenesis, vasculogenesis, and
angiogenic molecules production, hCG allows placenta to have adequate
blood supply during the invasion of uterus and optimum nutrition to the fetus.
The immunomodulatory properties of hCG are multiple. hCG has a positive
impact on uNK cells, regulating their proliferation, putatively via mannose
receptor (MR). Furthermore, hCG induces macrophage function, influences
dendritic cell differentiation and function, and inhibits Th1 cells. Finally, hCG
attracts Treg cells during early pregnancy and increases their frequency and
suppressive activity. LH and hCG share the same LHCG receptor but LH is
the only ligand of LHCG-R in mouse. hCG and LH are distinct molecules and
actions of hCG cannot be claimed for LH. Murine blastocysts express the Lh
gene and produce a bioactive LH signal thus showing that LH could be an
important actor for the early dialog between the murine embryo and its
mother. Data about the immunomodulatory roles of LH are scarce. LH could
contribute to fetal tolerance by acting on murine Treg cells, similarly to hCG.
LH would have also an impact on uNK cell recruitment.
(132). hCG treatment of abortion-prone female increases Treg
cell numbers and reduces abortion rates. Thus, among its numer-
ous functions during pregnancy affecting the fetus, placenta, and
uterus (133), hCG has multiple immunomodulatory roles. In par-
ticular, the hCG effects on Treg and uNK cells, two major immune
cell populations for pregnancy, demonstrate the importance of
this embryo signal as an immune regulator during pregnancy. The
different actions of hCG are summarized in Figure 2.
In humans, hCG shares its receptor with LH, a gonadotropin
produced by the pituitary gland. Essential for reproduction, its
fundamental functions are to initialize the final oocyte matura-
tion and trigger ovulation during estrous cycle. LH controls P4
production by CL and if pregnancy occurs, hCG takes over the
role of LH on P4 regulation. For pregnancy establishment, LH
contributes to decidualization triggering. Mouse genome does not
include a chorionic gonadotropin gene, and LH is therefore the
only ligand of LHCG-R in mice. But hCG and LH are distinct mol-
ecules and actions of hCG cannot be claimed for LH (134). Data
about the immunomodulatory roles of LH is scarce. Very recently,
Schumacher has shown that LH could contribute to fetal toler-
ance by acting on murine Treg cells (135), following the example of
hCG. Indeed, they showed that LH increases Treg cells peripherally
and locally. They found also that LH injections reduce the abor-
tion rates in abortion-prone mice. Earlier, we demonstrated that
murine blastocyst express the Lh gene and produce a bioactive LH
signal (136). Indeed, we detected Lh transcripts in blastocysts and
the LH protein in their culture media. This LH is able to stimulate
testosterone production by Leydig cells, and is thus bioactive. Fur-
thermore, we detected lhcgr transcripts in mouse endometrium
and the higher expression level was observed during the theoretical
embryo implantation period. Thus, we suggested that LH could
be an important actor for the early dialog between the murine
embryo and its mother (136). The results of Schumacher et al. con-
firm this hypothesis. Furthermore, Van den Heuvel et al. explored
adhesion properties of human lymphocytes in uterus and revealed
that adhesion was increased under LH surge (137). The authors
Frontiers in Endocrinology | Cellular Endocrinology July 2014 | Volume 5 | Article 106 | 6
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Polese et al. T-cell endocrine regulation during pregnancy
suggested that LH could activate adhesion molecules on the sur-
face of uNK precursors, thereby enhancing their recruitment in the
uterus. In their review, the same team puts forward the hypothesis
that cyclic hormonal variation could generate a favorable period
for uNK cell recruitment via expression of adhesion molecules.
They suggest again that LH would have an impact on uNK cell
recruitment (138). Altogether, those studies show that LH also
exerts immunomodulatory roles. LH can regulate Treg cells and
would act on recruitment of uNK cells. The study of immuno-
logical properties of LH is at the beginning but the expression
of LH receptor by T lymphocytes (124) suggests that other func-
tions could be explored. LH actions during murine gestation are
summarized in Figure 2.
CONCLUSION
Nowadays, uNK cells are considered as essential immune cells
for pregnancy establishment and maintenance. CD4+ T cells are
also important actors with Th2 being increased during pregnancy
while Th1 have to be decreased for gestation to run smoothly.
The importance of Treg cells for embryo implantation and preg-
nancy is also more and more evidenced. They are recruited before
implantation to induce a favorable environment for embryo nida-
tion. Afterwards, they are essential for maintenance of pregnancy.
On the other hand, decreased number or less efficient Treg cells
are implicated in fertility disorders. With regard to Th17 cells, the
few available studies seem to indicate that they have a negative
impact on fertility. Indeed, Th17 frequency is increased in infertile
patients. Concerning immune properties of pregnancy hormones,
it appears that they have positive impact on cells indispensable
for implantation and gestation. With the combination of its pro-
effects on Th2 and Treg cells, and anti-effects on Th1 and Th17
cells, P4 contributes clearly to establishment of favorable environ-
ment for pregnancy. E2 effects are more dependent on the context
but it seems that E2 promotes Treg and Th2 cells while inhibiting
Th1 cells.
Human chorionic gonadotropin positively influences the activ-
ities of Treg and uNK cells. This embryo signal is an essential actor
for the success of pregnancy, both as the well-known endocrine
factor regulating P4 secretion by the ovarian CL, but also as a
paracrine agent during implantation as well as an angiogenic
and immunologic mediator during the course of gestation. LH
immune properties begin to be studied but its positive impact on
Treg cells suggests that LH could be a considerable immunomodu-
lator. The timing of pregnancy hormones and CD4+ T cells levels
during human pregnancy is simplified on Figure 1. Of course,
endocrine system is not the only factor responsible for immune cell
recruitment and activation during pregnancy. It was showed that
Treg cells found during pregnancy react to paternal antigen (22,
24). Zhao et al. demonstrated that fetal alloantigens are responsi-
ble for Treg cell recruitment, excluding hormonal influence (139).
To finally conclude, both allogeneic and hormonal stimulation are
responsible for a harmonious regulation of the immune system
leading to a successful pregnancy.
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